Komori
dip (2379) · FactUpdated interim research and development expenses

Research and Development Expenses for the AI and RPA Business

First written in FY2020-Q3. . Latest entry: FY2027-H1.

24entries
7years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2020-Q3 – FY2027-H12020: 420202021: 420212022: 420222023: 320232024: 420242025: 220252026: 32026
Same theme, other companies
Decline in R&D spendingA theme 50 companies write about · 46 as a headwind · 4 as a tailwind

42 other companies' latest entry also says "Other".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 50 companies compared. The sentences above are computed from all 50.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1Updated interim research and development expensesAnnual report

    「Total R&D expenses for the current interim consolidated accounting period were ¥8 million.」

    The total R&D expenses for the current interim consolidated accounting period were disclosed as ¥8 million.
  2. FY2026Full-Year R&D Expense UpdatedAnnual report

    「Total R&D expenses for the current consolidated fiscal year were ¥15 million. These consisted mainly of development costs for AI agents.」

    R&D expenses focused primarily on AI agents totaled ¥15 million for the full fiscal year, down from ¥50.223 million in the previous fiscal year.
  3. 2026-04-14OtherEarnings

    「Total research and development expenses included in selling, general and administrative expenses」

    Total research and development expenses decreased from ¥50.223 million in the previous fiscal year to ¥15.553 million in the current fiscal year.
  4. FY2026-H1Updated interim research and development expensesAnnual report

    「Total R&D expenses for the current interim consolidated accounting period were ¥5 million.」

    The total R&D expenses for the current interim consolidated accounting period were disclosed as ¥5 million.
  5. FY2025Full-Year R&D Expense UpdatedAnnual report

    「Total R&D expenses for the current consolidated fiscal year were ¥50 million. These consisted mainly of development costs for AI agents.」

    R&D expenses focused primarily on AI agents totaled ¥50 million for the full fiscal year, up from ¥44 million in the previous fiscal year.
  6. FY2025-H1Updated interim research and development expensesAnnual report

    「Total R&D expenses for the current interim consolidated accounting period were ¥33 million.」

    The total R&D expenses for the interim cumulative period were updated to ¥33 million.
  7. FY2025-Q1Updated quarterly research and development expensesAnnual report

    「Total R&D expenses for the three months ended the first quarter were ¥14 million.」

    The total R&D expenses for the cumulative first quarter were updated to ¥14 million.
  8. FY2024Full-Year R&D Expense UpdatedAnnual report

    「Total R&D expenses for the fiscal year were ¥44 million. These were primarily development expenses for AI agents.」

    The company has disclosed full-year R&D expenses of ¥44 million, primarily for AI agent development.
  9. FY2024-Q3Updated quarterly research and development expensesAnnual report

    「Total R&D expenses for the nine months ended the third quarter were ¥26 million.」

    Total R&D expenses for the nine months ended the third quarter have been updated to ¥26 million.
  10. FY2024-Q2Updated quarterly research and development expensesAnnual report

    「Total R&D expenses for the six months ended the second quarter were ¥25 million.」

    The company has disclosed total R&D expenses of ¥25 million for the six months ended the second quarter.
  11. FY2024-Q1Updated quarterly research and development expensesAnnual report

    「Total R&D expenses for the three months ended the first quarter were ¥10 million.」

    The company has disclosed total R&D expenses of ¥10 million for the three months ended the first quarter.
  12. FY2023-Q3Updated quarterly research and development expensesAnnual report

    「No R&D expenses were incurred during the nine months ended the third quarter.」

    The company has disclosed that no R&D expenses were incurred during the nine months ended the third quarter.
  13. FY2023-Q2Updated quarterly research and development expensesAnnual report

    「No R&D expenses were incurred during the six months ended the second quarter.」

    The company has disclosed that no R&D expenses were incurred during the six months ended the second quarter.
  14. FY2023-Q1Quarterly research and development expense updateAnnual report

    「No R&D expenses were incurred during the three months ended the first quarter.」

    The company has disclosed that no R&D expenses were incurred during the three months ended the first quarter.
  15. FY2022Full-Year R&D Expense UpdatedAnnual report

    「Total R&D expenses for the fiscal year were ¥12.024 million. These were development expenses for the DX business.」

    The company has disclosed full-year R&D expenses of ¥12.024 million as development expenses for the DX business.
  16. FY2022-Q3Updated quarterly research and development expensesAnnual report

    「Total R&D expenses for the nine months ended the third quarter were ¥12 million.」

    The company has disclosed total R&D expenses of ¥12 million for the nine months ended the third quarter.
  17. FY2022-Q2Updated quarterly research and development expensesAnnual report

    「Total R&D expenses for the six months ended the second quarter were ¥10 million.」

    The company has disclosed total R&D expenses of ¥10 million for the six months ended the second quarter.
  18. FY2022-Q1Updated quarterly research and development expensesAnnual report

    「Total R&D expenses for the three months ended the first quarter were ¥2 million.」

    The company has disclosed total R&D expenses of ¥2 million for the three months ended the first quarter.
  19. FY2021Full-Year R&D Expense UpdatedAnnual report

    「Total R&D expenses for the fiscal year were ¥158.439 million. These were development expenses for the AI and RPA business.」

    The company has disclosed full-year R&D expenses of ¥158.439 million as development expenses for the AI and RPA business.
  20. FY2021-Q3Updated quarterly research and development expensesAnnual report

    「The total R&D expenses for the nine-month cumulative period of the current consolidated fiscal year were ¥122 million.」

    Cumulative R&D expenses related to the AI and RPA business and other activities have been updated to ¥122 million.
  21. FY2021-Q2Updated quarterly research and development expensesAnnual report

    「Total R&D expenses for the six months ended the second quarter were ¥89 million.」

    Total R&D expenses for the six months ended the second quarter have been updated to ¥89 million.
  22. FY2021-Q1Updated quarterly research and development expensesAnnual report

    「Total R&D expenses for the three months ended the first quarter were ¥47 million.」

    The company has disclosed total R&D expenses of ¥47 million for the three months ended the first quarter, relating to the AI and RPA business and other activities.
  23. FY2020Full-Year R&D Expense UpdatedAnnual report

    「Total R&D expenses for the fiscal year were ¥241.878 million. These were development expenses for the new AI and RPA business.」

    The company has disclosed full-year R&D expenses of ¥241.878 million as development expenses for the AI and RPA business.
  24. FY2020-Q3First statedAnnual report

    「Total R&D expenses for the nine months ended the third quarter were ¥136 million. These were development expenses for the new AI and RPA business.」

    The company has disclosed total R&D expenses of ¥136 million for the nine months ended the third quarter, attributable to the AI and RPA business.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for dip yet. It last moved in the Earnings of 2026-04-14: "Other".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Research and Development Expenses for the AI and RPA Business | dip Corporation (2379) | Komori